PortfoliosLab logoPortfoliosLab logo
IBIO vs. XBIT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

IBIO vs. XBIT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iBio, Inc. (IBIO) and XBiotech Inc. (XBIT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

Over the past 10 years, IBIO has underperformed XBIT with an annualized return of -52.43%, while XBIT has yielded a comparatively higher -16.62% annualized return.


IBIO

1D
4.89%
1M
19.88%
YTD
0.00%
6M
50.78%
1Y
95.28%
3Y*
-49.53%
5Y*
-69.23%
10Y*
-52.43%

XBIT

1D
-0.84%
1M
-7.06%
YTD
-0.84%
6M
-5.58%
1Y
-19.39%
3Y*
-24.92%
5Y*
-30.49%
10Y*
-16.62%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBIO vs. XBIT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IBIO
iBio, Inc.
0.00%-21.22%78.83%-84.59%-96.76%-47.71%320.00%-66.82%-58.14%-54.43%
XBIT
XBiotech Inc.
-0.84%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%28.93%-61.07%

Correlation

The correlation between IBIO and XBIT is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (10Y)
Calculated over the trailing 10-year period

0.10

Correlation (All Time)
Calculated using the full available price history since Apr 16, 2015

0.09

Fundamentals

Market Cap

IBIO:

$230.83M

XBIT:

$72.26M

EPS

IBIO:

-$0.38

XBIT:

-$1.32

PB Ratio

IBIO:

2.98

XBIT:

0.54

Total Revenue (TTM)

IBIO:

$300.00K

XBIT:

$0.00

Gross Profit (TTM)

IBIO:

-$230.00K

XBIT:

-$805.00K

EBITDA (TTM)

IBIO:

-$16.93M

XBIT:

-$42.42M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBIO vs. XBIT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBIO
IBIO Risk / Return Rank: 7171
Overall Rank
IBIO Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
IBIO Sortino Ratio Rank: 7676
Sortino Ratio Rank
IBIO Omega Ratio Rank: 7171
Omega Ratio Rank
IBIO Calmar Ratio Rank: 7272
Calmar Ratio Rank
IBIO Martin Ratio Rank: 6868
Martin Ratio Rank

XBIT
XBIT Risk / Return Rank: 2525
Overall Rank
XBIT Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 2525
Sortino Ratio Rank
XBIT Omega Ratio Rank: 2525
Omega Ratio Rank
XBIT Calmar Ratio Rank: 2424
Calmar Ratio Rank
XBIT Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBIO vs. XBIT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iBio, Inc. (IBIO) and XBiotech Inc. (XBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBIOXBITDifference
Sharpe ratioReturn per unit of total volatility

+1.20

Sortino ratioReturn per unit of downside risk

+2.31

Omega ratioGain probability vs. loss probability

1.23

0.97

+0.26

Calmar ratioReturn relative to maximum drawdown

1.78

-0.49

+2.28

Martin ratioReturn relative to average drawdown

3.38

-0.75

+4.13

IBIO vs. XBIT - Sharpe Ratio Comparison

The current IBIO Sharpe Ratio is 0.82, which is higher than the XBIT Sharpe Ratio of -0.38. The chart below compares the historical Sharpe Ratios of IBIO and XBIT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IBIOXBITDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.82

-0.38

+1.20

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.45

-0.48

+0.03

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.33

-0.22

-0.11

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

-0.23

0.00

Drawdowns

IBIO vs. XBIT - Drawdown Comparison

The maximum IBIO drawdown since its inception was -100.00%, which is greater than XBIT's maximum drawdown of -92.67%. Use the drawdown chart below to compare losses from any high point for IBIO and XBIT.


Loading charts...

Drawdown Indicators


IBIOXBITDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-92.67%

-7.33%

Max Drawdown (1Y)

Largest decline over 1 year

-53.75%

-39.43%

-14.32%

Max Drawdown (3Y)

Largest decline over 3 years

-96.51%

-78.56%

-17.95%

Max Drawdown (5Y)

Largest decline over 5 years

-99.93%

-87.21%

-12.72%

Max Drawdown (10Y)

Largest decline over 10 years

-99.98%

-90.72%

-9.26%

Current Drawdown

Current decline from peak

-99.99%

-91.27%

-8.72%

Average Drawdown

Average peak-to-trough decline

-86.67%

-70.11%

-16.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.29%

25.92%

+2.37%

Volatility

IBIO vs. XBIT - Volatility Comparison

iBio, Inc. (IBIO) has a higher volatility of 26.14% compared to XBiotech Inc. (XBIT) at 6.88%. This indicates that IBIO's price experiences larger fluctuations and is considered to be riskier than XBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBIOXBITDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.14%

6.88%

+19.26%

Volatility (6M)

Calculated over the trailing 6-month period

87.98%

27.26%

+60.72%

Volatility (1Y)

Calculated over the trailing 1-year period

117.98%

51.89%

+66.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

153.42%

64.04%

+89.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

156.96%

75.31%

+81.65%

Dividends

IBIO vs. XBIT - Dividend Comparison

Neither IBIO nor XBIT has paid dividends to shareholders.


PositionTTM20252024202320222021
IBIO
iBio, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%
XBIT
XBiotech Inc.
0.00%0.00%0.00%0.00%0.00%22.46%

Financials

IBIO vs. XBIT - Financials Comparison

This section allows you to compare key financial metrics between iBio, Inc. and XBiotech Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00M2.00M3.00M4.00M5.00M2022202320242025202600
(IBIO) Total Revenue
(XBIT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


IBIO and XBIT have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IBIO has higher volatility (26.14%) compared to XBIT (6.88%). In terms of maximum drawdown, IBIO dropped -100.00% vs XBIT's -92.67%.

IBIO currently has the higher Sharpe Ratio (0.82 vs -0.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBIO and XBIT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer